T0	Drug 63 66	SAF
T1	Disease 94 99	tumor
#2	AnnotatorNotes T1	DOID:162
T10	Drug 528 537	cisplatin
T11	Disease 554 568	ovarian cancer
#4	AnnotatorNotes T11	DOID:2394
T12	Drug 589 598	sorafenib
T13	Disease 612 625	breast cancer
#6	AnnotatorNotes T13	DOID:1612
T14	Drug 655 665	irinotecan
T15	Disease 679 694	colon carcinoma
#8	AnnotatorNotes T15	DOID:1520
T16	Disease 765 768	HCC
T17	Drug 795 798	SAF
T18	Drug 910 913	SAF
T19	Disease 927 933	tumors
#12	AnnotatorNotes T19	DOID:162
T2	Disease 113 116	HCC
T20	Disease 980 985	tumor
T24	Drug 1152 1155	SAF
T25	Disease 1152 1170	SAF-treated tumors
T27	Drug 1294 1297	SAF
T28	Disease 1294 1312	SAF-treated tumors
T29	Drug 1379 1382	SAF
T3	Drug 167 170	SAF
T30	Disease 1429 1432	HCC
T5	Disease 198 208	HCC tumors
#25	AnnotatorNotes T5	DOID:684
T6	Disease 349 365	malignant tumors
#26	AnnotatorNotes T6	DOID:162
T4	Collection 94 116	tumor growth in an HCC
R1	Response Arg1:T0 Arg2:T4	
#1	AnnotatorNotes T10	CHEMBL11359
#3	AnnotatorNotes T12	CHEMBL1336
#5	AnnotatorNotes T14	CHEMBL481
#7	AnnotatorNotes T2	DOID:684 
T7	Biomarker 214 223	ADC value
R2	Association Arg1:T7 Arg2:T6	
T8	Biomarker 496 506	ADC values
T9	Biomarker 751 761	ADC values
T22	Biomarker 939 961	increase in ADC values
R3	Association Arg1:T22 Arg2:T20	
T23	Biomarker 878 888	ADC values
R4	Response Arg1:T29 Arg2:T30	
T26	Gene-Protein 1245 1254	caspase-3
#9	AnnotatorNotes T26	HGNC:1504
T31	Gene-Protein 1267 1276	caspase-7
#10	AnnotatorNotes T31	HGNC:1508
#11	AnnotatorNotes T0	CHEBI:144227
T21	Chemical 1050 1051	E
T32	Biomarker 1110 1134	less compact cell spaces
T33	Biomarker 1082 1105	ncreased tumor necrosis
T34	Collection 1081 1134	Increased tumor necrosis and less compact cell spaces
T35	Chemical 1176 1177	H
T37	Chemical 1178 1179	E
T36	Biomarker 1194 1276	higher levels of the proapoptotic proteins cleaved caspase-3 and cleaved caspase-7
R5	Association Arg1:T34 Arg2:T25	
R6	Association Arg1:T36 Arg2:T28	
T38	Chemical 1048 1049	H
#13	AnnotatorNotes T25	not found
T56	Disease 390 395	tumor
T40	Disease 409 414	tumor
